Chordia Therapeutics Inc. Financial Overview
Chordia Therapeutics Inc.'s market cap is currently ¥7.09B. The company's EPS TTM is ¥-5.6; its P/E ratio is ―; Chordia Therapeutics Inc. is scheduled to report earnings on October 10, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
